Machine Learning

A new platform launches to connect accessible tech startups with users and investors, aiming to unify a fragmented but powerful innovation ecosystem.

Benchling launches Model Hub, an integrated platform to democratize AI in biotech, aiming to slash R&D timelines by embedding models into daily workflows.

A new benchmark shows top AI voice tools fail in non-English languages, challenging billion-dollar deployments and exposing deep-rooted linguistic bias.

Private equity firm Thurston Group launches Sensorium Clinical Research, a new network aiming to unify top trial sites and streamline medical innovation.

A new price feed for real-world assets like gold and Tesla promises continuous trading, challenging the 9-to-5 financial world and wooing institutions.

A biotech firm says it has grown functional human sperm in a lab and created embryos, a huge leap that could change millions of lives and spark ethical debate.

A $25M payment from partner Chiesi catapults Protalix to a profitable quarter, funding a promising new gout therapy and a broader rare disease strategy.

The new CROSSx Disclosed platform combines Wall Street-style trading relationships with blazing speed, aiming to lower costs and risks for institutions.

A new alliance aims to develop first-in-class drugs for Alzheimer's and Parkinson's by targeting chronic brain inflammation, a key driver of disease.

A new study reveals Efsubaglutide Alfa not only controls diabetes but may also improve the body's own insulin-producing cells, heralding a new era.

A new US-Taiwan partnership will equip unmanned boats with advanced AI, creating autonomous swarms to bolster the island's asymmetric defense strategy.

The world's leading sports academy installs a revolutionary gel track, using 'super shoe' principles to make athletes faster, fitter, and fresher.

With a novel drug for schizophrenia and deep financial backing, LB Pharmaceuticals is advancing a promising new therapy for complex mental illnesses.

The cell-engineering firm posted a smaller-than-expected loss and announced a share buyback, signaling confidence despite a dip in core Q1 revenue.

After two rejections and a dramatic financial restructuring, Atara Biotherapeutics has a clear path to resubmit its key cancer therapy to the FDA.

AWE 2026 honors XR legends, unveils groundbreaking art and research, and champions a future where spatial AI empowers, not replaces, humanity.

The parent of Stop & Shop and Food Lion has hired a top data scientist. Here's how this move will reshape your shopping experience and the grocery industry.

New research reveals over half of fleet operators are dissatisfied with telematics, citing a major gap between promised benefits and real-world results.

Plaud's new AI platform, Plaud Team, moves beyond note-taking to create a shared intelligence layer from meetings, calls, and in-person discussions.

A new AI sales platform from Zig.ai aims to replace entire tech stacks with autonomous agents, promising to automate prospecting and reshape the sales role.